FREE Account Opening + No Clearing Fees

Windlas Biotech Limited IPO (Windlas Biotech IPO) Detail

August 4, 2021 - August 6, 2021

Windlas Biotech IPO is a book built issue of Rs 401.54 crores. The issue comprises of fresh issue of Rs 165.00 crore and offer for sale of 0.51 crore shares.

Windlas Biotech IPO bidding started from August 4, 2021 and ended on August 6, 2021. The allotment for Windlas Biotech IPO was finalized on Wednesday, August 11, 2021. The shares got listed on BSE, NSE on August 16, 2021.

Windlas Biotech IPO price band is set at ₹448 to ₹460 per share. The minimum lot size for an application is 30 Shares. The minimum amount of investment required by retail investors is ₹13,800.

Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd), Iifl Securities Ltd and SBI Capital Markets Limited are the book running lead managers of the Windlas Biotech IPO, while Link Intime India Private Ltd is the registrar for the issue.

Refer to Windlas Biotech IPO RHP for detailed information.

Windlas Biotech IPO Details

IPO Date August 4, 2021 to August 6, 2021
Listing Date August 16, 2021
Face Value ₹5 per share
Price Band ₹448 to ₹460 per share
Lot Size 30 Shares
Total Issue Size[.] shares
(aggregating up to ₹401.54 Cr)
Fresh Issue[.] shares
(aggregating up to ₹165.00 Cr)
Offer for Sale5,142,067 shares of ₹5
(aggregating up to ₹236.54 Cr)
Issue Type Book Built Issue IPO
Listing At BSE, NSE

Windlas Biotech IPO Reservation

Windlas Biotech IPO offers 6,136,252 shares. 1,723,700 (28.09%) to QIB, 1,323,766 (21.57%) to NII, 3,088,786 (50.34%) to RII. 102,959 RIIs will receive minimum 30 shares and (sNII) and (bNII) will receive minimum 450 shares. (in case of oversubscription)

Investor Category Shares OfferedMaximum Allottees
Anchor Investor Shares Offered-NA
QIB Shares Offered1,723,700 (28.09%)NA
NII (HNI) Shares Offered1,323,766 (21.57%)
Retail Shares Offered3,088,786 (50.34%)102,959
Total Shares Offered6,136,252 (100%)

Windlas Biotech IPO Timeline (Tentative Schedule)

Windlas Biotech IPO opens on August 4, 2021, and closes on August 6, 2021.

IPO Open Date Wednesday, August 4, 2021
IPO Close Date Friday, August 6, 2021
Basis of Allotment Wednesday, August 11, 2021
Initiation of Refunds Thursday, August 12, 2021
Credit of Shares to Demat Friday, August 13, 2021
Listing Date Monday, August 16, 2021
Cut-off time for UPI mandate confirmation 5 PM on August 6, 2021

Windlas Biotech IPO Lot Size

Investors can bid for a minimum of 30 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.

Application Lots Shares Amount
Retail (Min) 1 30 ₹13,800
Retail (Max) 14 420 ₹193,200
Lot Size Calculator

Windlas Biotech IPO Promoter Holding

Ashok Kumar Windlass, Hitesh Windlass, Manoj Kumar Windlass, and AKW WBL Family Pvt Trust are the company promoters.

Share Holding Pre Issue 78%
Share Holding Post Issue 65.16%

About Windlas Biotech Limited

Incorporated in 2001, Windlas Biotech Ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in India. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.

It further sells its own branded products in the trade generics and OTC markets. Currently, the focus of the company is to launch complex generic products in the chronic therapeutic category related to lifestyle-related disorders. The business operates in 3 verticals; 1. CDMO Products and services, 2. Domestic trade generics and Over-the-counter (OTC) market (nutraceutical and health supplement products), and 3. Export.

Leading pharma companies i.e. Pfizer Ltd, Sanofi India Ltd, Cadila Healthcare Ltd, Emcure Pharmaceuticals Ltd, Eris Lifesciences Ltd, Intas Pharmaceuticals Ltd, and Systopic Laboratories Private Limited are some of the marquee customers of Windlas Biotech. Its manufacturing facilities are located at Dehradun with an installed operating capacity of 7,063.83 million tablets/ capsules, 54.46 million pouch/ sachet, and 61.08 million liquid bottles.

Competitive strengths

  • Leading market player in the domestic pharmaceutical formulation CDMO segment.
  • Strong focus on the chronic therapeutic category.
  • state-of-the-art manufacturing facilities in Dehradun, Uttarakhand.
  • Professional and experienced Promoters and a senior management team.
  • An innovative product portfolio of complex generic products.
  • Robust financial performance track record.

Company Financials

Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 2,961.23 3,384.88 2,981.80
Total Revenue 4,306.95 3,313.39 3,115.25
Profit After Tax 155.70 162.13 638.22

Objects of the Issue (Windlas Biotech IPO Objectives)

  • To purchase equipment required for capacity expansion of our existing facility at Dehradun Plant IV.
  • To finance incremental working capital requirements of the company.
  • Repayment/prepayment of company's borrowings.
  • General corporate purposes.

Windlas Biotech IPO Review (May apply)

[Dilip Davda]  Despite growth in its top lines, WBL has posted declining trends for bottom lines in order to clear its slate. Based on its financial parameters, the issue is aggressively priced. All recent moves will take about two years to be on a fast forward mode. Thus it is purely a long term bet at the current valuations that discounts all near term positives. Cash surplus investors may consider it with a long term perspective. Read detail review...

Windlas Biotech IPO Subscription Status (Bidding Detail)

The Windlas Biotech IPO is subscribed 22.44 times on August 6, 2021 6:50:00 PM. The public issue subscribed 24.22 times in the retail category, 24.40 times in the QIB category, and 15.73 times in the NII category. Check Day by Day Subscription Details (Live Status)

Application Wise IPO Subscription (Retail): 20.63 times

CategorySubscription (times)

Windlas Biotech IPO Prospectus

Windlas Biotech IPO Rating

Rating:Rated 4.0 stars
Vote Here ...

Windlas Biotech IPO Listing Details

Listing Date August 16, 2021
BSE Script Code 543329
Final Issue Price ₹460 per share

Pre-Open Session - NSE Pre-Open Session - BSE

Listing Day Trading Information

Price Details
Final Issue Price
Last Trade

Check IPO Performance…

Windlas Biotech Limited Contact Details

Windlas Biotech Limited
40/1, Mohabewala Industrial Area,
Dehradun, 248110

Phone: +91 135 6608000

Windlas Biotech IPO Registrar

Link Intime India Private Ltd

Phone: +91-22-4918 6270

Windlas Biotech IPO - Buy or Not

Windlas Biotech IPO Recommendation Summary

Review By Subscribe Neutral Avoid
Brokers 2 1 1
Members 0 0 0

Read All Reviews Post Your Review Manage Reviews

Windlas Biotech IPO FAQs

Windlas Biotech IPO is a main-board IPO of [.] equity shares of the face value of ₹5 aggregating up to ₹401.54 Crores. The issue is priced at ₹448 to ₹460 per share. The minimum order quantity is 30 Shares.

The IPO opens on August 4, 2021, and closes on August 6, 2021.

Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Zerodha customers can apply online in Windlas Biotech IPO using UPI as a payment gateway. Zerodha customers can apply in Windlas Biotech IPO by login into Zerodha Console (back office) and submitting an IPO application form.

Steps to apply in Windlas Biotech IPO through Zerodha

  1. Visit the Zerodha website and login to Console.
  2. Go to Portfolio and click the IPOs link.
  3. Go to the 'Windlas Biotech IPO' row and click the 'Bid' button.
  4. Enter your UPI ID, Quantity, and Price.
  5. ‘Submit’ IPO application form.
  6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Visit Zerodha IPO Application Process Review for more detail.

The Windlas Biotech IPO opens on August 4, 2021 and closes on August 6, 2021.

Windlas Biotech IPO lot size is 30 Shares, and the minimum amount required is ₹13,800.

You can apply in Windlas Biotech IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Windlas Biotech IPO will be done on Wednesday, August 11, 2021, and the allotted shares will be credited to your demat account by Friday, August 13, 2021. Check the Windlas Biotech IPO allotment status.

The Windlas Biotech IPO listing date is on August 16, 2021.
Open an Instant Account with Zerodha

Windlas Biotech IPO Message Board

Ranked Members of Forum  Ranked Members | Members with Most Likes



247. mvsmr |   Link |  Bookmark |September 20, 2021 12:32:34 PM
Windlas never touched the IPO price, should I sell the allotted lot for loss or any hope to get some gains in future?
246. Samruddhi Pai |   Link |  Bookmark |September 1, 2021 11:25:02 AM
245. Samruddhi Pai |   Link |  Bookmark |August 30, 2021 6:30:09 PM
244. MS ASSOCIATE |   Link |  Bookmark |August 27, 2021 6:18:14 PM
Aptus Value share price close above issue price
244.1. mvsmr |   Link |  Bookmark |September 6, 2021 5:18:06 PM
@MS Associate, have you sold your shares or still holding them?
243. Nagur |   Link |  Bookmark |August 25, 2021 12:30:08 PM
Hai sir,
My name is shaik Nagur meera i still cant get ipo refund amount pls check for me
Client id : 20452722
DP id : INE301774
242. Cyberdude |   Link |  Bookmark |August 23, 2021 11:52:05 AM (200+ Posts)
how much more will this go down? this is a profit-making company and in the niche domain still, prices are going down. why?
The same is happening with Glenmark life science as well. both of them are giving loss right now :(.
241. Justaninvestor |   Link |  Bookmark |August 20, 2021 11:39:39 PM
Is it good around 300.
240. Ramsan |   Link |  Bookmark |August 20, 2021 5:32:30 PM
Hi anybody else yet to get refund!?
tomoro is mandate expiry Can we expect tomoro
Or else what to do
Please guide
240.7. Unknown soul |   Link |  Bookmark |August 23, 2021 4:44:34 PM
Okay pls let me know once you got the amount
240.8. Ramsan |   Link |  Bookmark |August 24, 2021 1:44:51 PM
Finally got it
239. RajK |   Link |  Bookmark |August 20, 2021 8:24:21 AM
Let me Hold this? Or sell. Guide me. 2500 loss in this script.
238. Subbiah Ramanathan |   Link |  Bookmark |August 16, 2021 1:54:15 PM
eagle eye said premium is 80+5., what happened? she failed in sona comstar also. but u people say she only quoted GMP. . shwe should not post such GMP,, NEW INVESTORS ARE LOOSING MONEY, BEC SHE HAS QUOTED GMP
238.9. dhruvc |   Link |  Bookmark |August 19, 2021 8:56:25 AM
GMP before listing does not guarantee gains on listing - GMP changes everyday. I do not see any fault of the person who posted the GMP. Investors investing in the IPO should not blindly apply on GMP, but look on the long term prospects of the stock as well. In this IPO rally, even kachra stocks like chemplast had GMP irrespective of such high valuations.

And irrespective of sound valuations, bright future and good GMP, risk is always there and listing gains would not be 100% guaranteed. Hence, only use your surplus cash.
238.10. DuckkyDuck |   Link |  Bookmark |August 20, 2021 1:20:16 AM
Top Contributor Top Contributor (200+ Posts, 200+ Likes)
This is all new members mistake. All these new people coming to market without any knowledge. They just listen from here and there, and buy based on GMP. They just zomato is giving 80% return and jump in stock market. They dont do any research. They dont know the "downs" of market bcoz they have never seen that in these short period of time. But we are here from long, and know what market can do.
GMP posting and listing is not related. Also she just posted the GMP, not recommended you to buy. If she didn''t recommended you to buy, why u bought??? If others dont have knowledge and you have so much knowledge you shouldn''t have bought right? And in worst case if someone recommended you to buy something, you have the ultimate decision. You are responsible for your losses, not anyone else.
Its like any Ad on tv. There are ADs of lots of cooking oil or may be lots of cars. But they are just Ads. You have to decide whether u want car, which car is best suited for you, what you want in it, what price etc.
237. Mr.Yash.Raghuvanshi |   Link |  Bookmark |August 16, 2021 12:20:43 PM
Can anyone tell me what to do with Windlas hold until Q1 Results or sell at loss ?
I have 2 lot. Pls suggest something I''m new
237.3. Srinijinx |   Link |  Bookmark |August 18, 2021 1:36:50 PM
Please book loss. We can enter later
237.4. Srinijinx |   Link |  Bookmark |August 19, 2021 9:19:08 PM
236. Roopa shree p |   Link |  Bookmark |August 13, 2021 10:49:35 AM
I''m not refunded my blocked amount any one tell me when it''s refunded
236.3. Ramsan |   Link |  Bookmark |August 19, 2021 8:48:21 AM
@unknown no 😭
236.4. Unknown soul |   Link |  Bookmark |August 22, 2021 12:56:04 PM
Did you got refund?
235. gundu anna |   Link |  Bookmark |August 17, 2021 2:28:37 PM (500+ Posts, 100+ Likes)
When excessive retail punting and on first day get oversubscribed several times, these type of issue must come to market to weed out the speculators.
234. rsk |   Link |  Bookmark |August 16, 2021 9:29:27 PM
IPO Mentor IPO Mentor (600+ Posts, 300+ Likes)
16-Aug-21      WINDLAS      Windlas Biotech Limited      ICICI LTD TRADING A/C      SELL      122350      417.62      -
233. Kailash sharma |   Link |  Bookmark |August 16, 2021 9:19:05 PM
Top Contributor Top Contributor (200+ Posts, 100+ Likes)
Applying in IPO if profitable then like senior mambers if loss then abuset them it''s totally wrong if you are investing or trading in share market only 5 to 10% loss is not a big one.
232. Ipolobo |   Link |  Bookmark |August 16, 2021 6:06:58 PM
Have one lot, is it advisable to buy more to average down ?
232.1. Mr. Singh |   Link |  Bookmark |August 16, 2021 7:50:57 PM
IPO Mentor IPO Mentor (700+ Posts, 500+ Likes)
231. Regulagedda Ambica Prasad |   Link |  Bookmark |August 16, 2021 7:05:07 PM
Top Contributor Top Contributor (400+ Posts, 200+ Likes)
Started bottom fishing at 405
230. JUSTVIKRANT |   Link |  Bookmark |August 16, 2021 6:44:10 PM
Well said . + - banta hai, sirf uper jana thik nahi.
229. Cautious ipo |   Link |  Bookmark |August 6, 2021 11:59:13 AM
IPO Guru IPO Guru (1900+ Posts, 1100+ Likes)
Listing below 400 ???
229.2. Rahul Popat |   Link |  Bookmark |August 7, 2021 9:21:33 AM (200+ Posts, 400+ Likes)
In dreams
229.3. Cautious ipo |   Link |  Bookmark |August 16, 2021 6:43:28 PM
IPO Guru IPO Guru (1900+ Posts, 1100+ Likes)
Test 405 atleast
228. arunARUN |   Link |  Bookmark |August 16, 2021 4:42:50 PM
IPO Guru IPO Guru (1900+ Posts, 1600+ Likes)
Salute to all who give out GMP at personal risk of reputation. Sad part is that participants dont understand that grey market lacks depth and is expected to be more volatile. Grey saudas are useful for those who sell kostak or subject to (non greedy- earning for lending name without taking risk)
There are poor comments specially by new members whose understanding of market is very poor. All i can say is that god give them some gyan by making them lose some money
228.1. Spock 🖖 |   Link |  Bookmark |August 16, 2021 5:28:35 PM
60% who posts GMP here are referring GMP from other 30% member''s post and writing here with +-5-10.
This 60% don''t even deal in GMP, they just want to increase comments count to achieve forum tags.